查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971000

兽用镇静剂市场－全球产业规模、份额、趋势、机会、预测：按类型、给药途径、地区和竞争格局划分，2021-2031年

Animal Sedative Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine), By Route of Administration (Oral, Parenteral), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球动物镇静剂市场预计将从 2025 年的 1.3204 亿美元成长到 2031 年的 1.7344 亿美元，复合年增长率为 4.65%。

这些药物对牲畜和伴侣动物至关重要，有助于放鬆身心、减轻焦虑，并确保它们在运输和兽医手术过程中保持静止。推动成长的主要因素包括外科手术数量的增加以及关于安全操作的动物福利法规的日益严格。此外，宠物的人性化趋势也促使饲主在先进的医疗保健方面投入更多资金。例如，根据美国宠物用品协会 (APPA) 的报告，预计到 2024 年，美国宠物产业的总支出将达到 1,520 亿美元，这凸显了该市场对动物健康领域的巨大经济贡献。

市场概览
预测期 2027-2031
市场规模：2025年 1.3204亿美元
市场规模：2031年 1.7344亿美元
复合年增长率：2026-2031年 4.65%
成长最快的细分市场 醋丙嗪
最大的市场 北美洲

儘管兽药市场前景广阔，但由于其严格的监管核准框架，仍面临许多挑战。製造商必须投入大量时间和资金来向国际组织证明产品的安全性和有效性，这导致市场进入门槛极高。这种复杂的合规环境常常延缓新配方的上市，并限制了小型动物产品的供应。因此，这些监管障碍在很大程度上限制了市场发展，并阻碍了该领域的创新步伐。

市场驱动因素

全球宠物饲养量的不断增长以及动物拟人化的趋势，正成为全球动物镇静剂市场的主要驱动力。这是因为饲主越来越将宠物视为家庭成员，并要求它们获得最高标准的兽医护理。这种文化转变推动了对镇静剂的需求，以确保患者在影像影像检查、牙科治疗和复杂外科手术过程中的舒适和安全。市场潜力巨大，欧洲动物及动物保健联合会（FEDIAF）2025年6月发布的《事实与数据》报告证实了这一点，该报告指出，欧洲将有1.39亿个家庭至少拥有一隻宠物。这种需求带来的经济影响体现在主要产业参与者的成功上。例如，硕腾（Zoetis）在2025年2月的财报中披露，2024财年的总收入达到93亿美元，显示全球对动物保健产品的投资庞大。

此外，工业化畜牧养殖和畜牧生产的扩张是市场成长的主要驱动力，使得镇静剂在畜群管理、运输和小型手术中不可或缺。随着肉类畜价值的提升，生产者优先考虑符合动物福利标准的镇静方法，以防止因受伤和压力导致的体重下降。该行业的规模庞大，美国农业部于2025年4月发布的《2024年家禽生产和价值概要》便印证了这一点，该概要估计2024年美国肉鸡产量将达到454亿美元。因此，农业生产集约化的不断提高导致镇静剂製剂的采购量增加，以维持生产力、保障工人安全并符合国际动物福利标准。

市场挑战

兽药严格的监管核准流程严重阻碍了全球动物镇静剂市场的发展。生产商必须克服高昂的资金投入和漫长的审批流程，才能获得国际监管机构要求的安全性和有效性数据。对于牲畜镇静剂而言，这项挑战尤其严峻，因为牲畜镇静剂需要严格的停药期以确保食品安全；而伴侣动物产品则需要进行广泛的物种特异性耐受性测试。这些严格的合规标准延缓了新化合物的上市，并抑制了对少数物种治疗药物的投资，因为这些药物的潜在收益往往不足以弥补巨额的监管成本。

如此严格的监管环境不仅扼杀了创新，也缩小了可供选择的产品范围。随着合规成本的上升，製造商可能被迫将现有低利润配方撤出市场，从而限制兽医可用的治疗方案。这些法规的影响在近期的行业统计数据中显而易见。根据加拿大动物健康研究所2024年的报告，过去八年中，市场上获得许可的动物用药品数量下降了42.3%，主要原因是监管成本上升和行政压力增加。这些数据表明，监管负担正在透过减少基本药物的多样性和可及性，直接阻碍市场扩张。

市场趋势

随着宠物饲主寻求药物疗法来应对烟火、雷暴和旅行等非手术压力因素，市场格局正在重塑，对噪音恐惧和情境性焦虑治疗的需求日益增长。这一趋势正将焦点从传统镇静剂转向特定配方，例如起效迅速且作用可逆的口腔黏膜凝胶，以便在家中进行焦虑管理。 Orion Co., Ltd. 于 2024 年 10 月发布的《2024 年中期报告（1 月至 9 月）》充分体现了这一细分市场的商业性实力。报告显示，包括噪音焦虑治疗药物在内的兽用镇静剂在 2024 年前九个月的销售额达到 2,580 万欧元。这表明，兽医学界在关注宠物身心健康的同时，也越来越重视其行为健康。

此外，无恐惧兽医标准的普及正在改变临床工作流程，强制要求在就诊前使用预检药物（PVP）来减轻患者的压力。这个通讯协定的改变导致常规检查和小型手术中抗焦虑药物和镇静剂的处方量增加，从而创造了一条独立于手术麻醉的稳定收入来源。这些低压力方法的快速普及在产业趋势中显而易见，美国动物医院协会（AAHA）宣布，截至2024年3月，已有超过32万名兽医专业人员和宠物专科医生加入了无恐惧计画。这项广泛的认证进一步增加了对口服镇静剂的需求，这些药物可以提高遵守用药，并确保与兽医人员的安全互动。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：兽用镇静剂全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（醋丙嗪、Butorphanol、地托咪定、罗米非定、赛拉嗪）
    • 给药途径（口服、注射）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美兽用镇静剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲兽用镇静剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区动物镇静剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲动物镇静剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲动物镇静剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球动物镇静剂市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Zoetis Inc
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Inc
  • Virbac SA
  • Dechra Pharmaceuticals Limited
  • Orion Corporation
  • Vetoquinol SA
  • Bimeda, Inc.
  • Chanelle Pharma Group

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19183

The Global Animal Sedative Market is projected to expand from USD 132.04 Million in 2025 to USD 173.44 Million by 2031, registering a CAGR of 4.65%. These pharmacological agents are essential for livestock and companion animals, serving to induce relaxation, reduce anxiety, and ensure immobilization during transport or veterinary interventions. Growth is primarily driven by an increasing number of surgical procedures and a stricter adherence to animal welfare regulations regarding safe handling. Additionally, the trend of pet humanization encourages owners to spend more on advanced medical care; for instance, the American Pet Products Association reported that total U.S. pet industry expenditures hit $152 billion in 2024, highlighting the significant financial dedication to animal health that underpins this market.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 132.04 MIllion
Market Size 2031USD 173.44 MIllion
CAGR 2026-20314.65%
Fastest Growing SegmentAcepromazine
Largest MarketNorth America

Despite these growth prospects, the market faces substantial obstacles due to the stringent regulatory approval frameworks for veterinary pharmaceuticals. Manufacturers must invest considerable time and capital to prove safety and efficacy to international bodies, creating high entry barriers. This complex compliance environment frequently postpones the launch of new formulations and restricts the availability of products for minor species. Consequently, these regulatory hurdles limit broader market development and hinder the pace of innovation within the sector.

Market Driver

The rising trend of global pet ownership and the humanization of animals act as major catalysts for the Global Animal Sedative Market, as owners increasingly treat pets as family members requiring top-tier veterinary attention. This cultural evolution spurs demand for sedatives needed during diagnostic imaging, dental work, and complex surgeries to ensure patient comfort and safety. The market potential is vast, evidenced by the FEDIAF 'Facts & Figures' report from June 2025, which noted that 139 million European households own at least one pet. The economic impact of this bond is reflected in the success of key industry players; for example, Zoetis reported a total revenue of $9.3 billion for 2024 in its February 2025 results, signaling massive global investment in animal wellness products.

Furthermore, the expansion of industrial animal agriculture and livestock production drives significant market growth, requiring sedatives for herd management, transportation, and minor surgeries. As the value of food animals increases, producers are prioritizing welfare-compliant sedation to prevent injury and stress-related weight loss. The scale of this sector is immense, as highlighted by the USDA's 'Poultry - Production and Value 2024 Summary' released in April 2025, which valued U.S. broiler production at $45.4 billion in 2024. Accordingly, the intensification of farming operations leads to higher procurement of sedative formulations to maintain productivity, ensure handler safety, and satisfy international welfare standards.

Market Challenge

Stringent regulatory approval processes for veterinary pharmaceuticals represent a major hurdle to the growth of the global animal sedative market. Manufacturers must navigate high capital costs and lengthy timelines to produce the safety and efficacy data required by international regulatory bodies. This challenge is particularly acute for livestock sedatives, which demand precise withdrawal periods to guarantee food safety, while companion animal products require extensive testing for species-specific tolerability. These rigorous compliance standards often delay the release of new compounds and discourage investment in treatments for minor species, where the potential returns often fail to cover the steep regulatory expenses.

This environment of intense scrutiny not only stifles innovation but also contracts the range of available products. As the cost of compliance escalates, manufacturers may withdraw existing low-margin formulations, thereby limiting the therapeutic options accessible to veterinarians. The impact of these restrictions is clear in recent industry statistics; the Canadian Animal Health Institute reported in 2024 that the number of licensed veterinary drugs on the market had dropped by 42.3% over the previous eight years, a decline largely driven by rising regulatory fees and administrative pressures. Such data demonstrates how regulatory burdens directly impede market expansion by reducing the diversity and availability of essential pharmaceutical products.

Market Trends

The market is being reshaped by the growing demand for therapeutics addressing noise aversion and situational anxiety, as pet owners seek pharmacological remedies for non-surgical stressors like fireworks, thunderstorms, and travel. This trend is shifting focus from traditional immobilization agents toward specific formulations, such as oromucosal gels, which provide rapid onset and reversibility for managing anxiety at home. The commercial strength of this niche is highlighted by Orion Corporation's 'Interim Report 1-9/2024' from October 2024, which showed sales of animal sedatives, including noise anxiety treatments, reaching EUR 25.8 million for the first nine months. This indicates a growing emphasis on behavioral wellness alongside physical health in veterinary care.

Additionally, the mainstream adoption of Fear-Free veterinary practice standards is transforming clinical workflows by necessitating the use of Pre-Visit Pharmaceuticals (PVPs) to reduce patient stress prior to appointments. This protocol shift is driving prescriptions for anxiolytics and sedatives for routine exams and minor procedures, generating a consistent revenue stream separate from surgical anesthesia. The swift uptake of these low-stress techniques is evident in the industry landscape; the American Animal Hospital Association noted in March 2024 that over 320,000 veterinary and pet professionals have registered for Fear Free programs. This widespread certification fuels the need for oral sedative options that improve compliance and ensure safer interactions for veterinary staff.

Key Market Players

  • Zoetis Inc
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Inc
  • Virbac S.A.
  • Dechra Pharmaceuticals Limited
  • Orion Corporation
  • Vetoquinol SA
  • Bimeda, Inc.
  • Chanelle Pharma Group

Report Scope

In this report, the Global Animal Sedative Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Sedative Market, By Type

  • Acepromazine
  • Butorphanol
  • Detomidine
  • Romifidine
  • Xylazine

Animal Sedative Market, By Route of Administration

  • Oral
  • Parenteral

Animal Sedative Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Sedative Market.

Available Customizations:

Global Animal Sedative Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Sedative Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
    • 5.2.2. By Route of Administration (Oral, Parenteral)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Animal Sedative Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Route of Administration
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Animal Sedative Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Route of Administration
    • 6.3.2. Canada Animal Sedative Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Route of Administration
    • 6.3.3. Mexico Animal Sedative Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Route of Administration

7. Europe Animal Sedative Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Route of Administration
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Animal Sedative Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Route of Administration
    • 7.3.2. France Animal Sedative Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Route of Administration
    • 7.3.3. United Kingdom Animal Sedative Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Route of Administration
    • 7.3.4. Italy Animal Sedative Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Route of Administration
    • 7.3.5. Spain Animal Sedative Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Route of Administration

8. Asia Pacific Animal Sedative Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Route of Administration
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Animal Sedative Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Route of Administration
    • 8.3.2. India Animal Sedative Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Route of Administration
    • 8.3.3. Japan Animal Sedative Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Route of Administration
    • 8.3.4. South Korea Animal Sedative Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Route of Administration
    • 8.3.5. Australia Animal Sedative Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Route of Administration

9. Middle East & Africa Animal Sedative Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Route of Administration
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Animal Sedative Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Route of Administration
    • 9.3.2. UAE Animal Sedative Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Route of Administration
    • 9.3.3. South Africa Animal Sedative Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Route of Administration

10. South America Animal Sedative Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Route of Administration
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Animal Sedative Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Route of Administration
    • 10.3.2. Colombia Animal Sedative Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Route of Administration
    • 10.3.3. Argentina Animal Sedative Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Route of Administration

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Animal Sedative Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boehringer Ingelheim International GmbH
  • 15.3. Merck & Co., Inc.
  • 15.4. Elanco Animal Health Inc
  • 15.5. Virbac S.A.
  • 15.6. Dechra Pharmaceuticals Limited
  • 15.7. Orion Corporation
  • 15.8. Vetoquinol SA
  • 15.9. Bimeda, Inc.
  • 15.10. Chanelle Pharma Group

16. Strategic Recommendations

17. About Us & Disclaimer